Darvadstrocel for perianal fistulae is reimbursed by European national health systems (Spain, France, Germany, Italy) following conditional EU approval, typically with gastroenterology authorisation. Systemic MSC remission therapy is not reimbursed by any major insurance scheme; classified as investigational. US insurance does not cover either indication. Out-of-pocket payment is standard for non-fistula MSC therapy; fistula therapy may be partially covered in EU depending on national formulary inclusion and prior authorisation criteria.
Darvadstrocel for perianal fistulae costs approximately €7,000–9,500 per application in European centres. Systemic MSC induction therapy for active Crohn's or ulcerative colitis costs €6,000–8,000 per infusion protocol. Multiple fistulae or combined induction+maintenance regimens escalate costs to €12,000–20,000+ per year. Insurance coverage varies significantly: EU approved indication (perianal fistulae) is reimbursed by several national healthcare systems (Spain, France, Germany) with prior authorisation; systemic IBD remission therapy is rarely covered, classified as investigational. Out-of-pocket payment is standard for non-fistula indications.
Sunt un candidat? → · Crohn's & IBD: full overview → · Cost Boala Crohn și IBD → · Cost →
Revizuit medical de echipa editorială a StemCellAtlas cu Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) ale clinicii partenere Stem Plus (Sofia), în funcție de orientările ISSCR, FDA și EMA. Educational information, not medical advice; figures indicative.
Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.
Evaluare medicală gratuită